IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,234 | +10.3% | 196,200 | -4.3% | 0.00% | 0.0% |
| Q1 2024 | $1,119 | +12.7% | 205,092 | +4.5% | 0.00% | 0.0% |
| Q4 2023 | $993 | +221.4% | 196,200 | 0.0% | 0.00% | +100.0% |
| Q3 2023 | $309 | -41.4% | 196,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $527 | +56.8% | 196,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $336 | -64.7% | 196,200 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $951 | -99.9% | 196,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $947,000 | +30.8% | 196,200 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $724,000 | -37.4% | 196,200 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $1,156,000 | +344.6% | 196,200 | +367.1% | 0.00% | +200.0% |
| Q4 2021 | $260,000 | -33.2% | 42,000 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $389,000 | -32.6% | 41,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $577,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |